登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《LANCET，2月24日，COVID-19 pneumonia: what has CT taught us?》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-02-25

  • COVID-19 pneumonia: what has CT taught us?

    Elaine Y P Lee, Ming-Yen Ng, Pek-Lan Khong

    Published:February 24, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30134-1

    In late December, 2019, a cluster of cases of viral pneumonia was linked to a seafood market in Wuhan (Hubei, China), and was later determined to be caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously known as 2019-nCoV). The genome sequence of SARS-CoV-2 is similar to, but distinct from, those of two other coronaviruses responsible for large-scale outbreaks in the past: severe acute respiratory syndrome coronavirus (SARS-CoV; about 79% sequence identity) and Middle East respiratory syndrome coronavirus (MERS-CoV; about 50%).

  • 原文来源：https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30134-1/fulltext
15浏览量
原文链接
相关报告

  • 《2月24日_CT影像在COVID-19肺炎诊断中的作用》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-02-27
    • 1.时间：2020年2月24日 2.机构或团队：香港大学李嘉诚医学院放射诊断学系 3.事件概要： The Lancet Infectious Diseases于2月24日出版了香港大学李嘉诚医学院放射诊断学系发表的评论文章“COVID-19 pneumonia: what has CT taught us?”。文章指出，CT已成为协助诊断和治疗2019新型冠状病毒病201（COVID-19）肺炎患者的重要影像学手段，该文献结合有关COVID-19肺炎影像学表现的报道进行了述评。 该篇评论强调了华中科技大学同济医学院附属协和医院放射科等发表的论文对COVID-19肺炎影像学研究的贡献，包括提供了与症状发作有关的CT变化演变的间接证据。文章指出，关于这种新型传染性病毒性肺炎还有很多的知识要学习，关于CT表现与临床严重程度及进展的相关性，基线CT或时间变化对疾病预后的预测价值，以及关于COVID-19引起的急性肺损伤的后遗症还需要进行更多的研究。 4.附件： 原文链接： https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30134-1/fulltext
    33浏览量
    原文链接

  • 《LANCET，2月12日，What are the risks of COVID-19 infection in pregnant women?》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-02-13
    • What are the risks of COVID-19 infection in pregnant women? Jie Qiao Published:February 12, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30365-2 Since December, 2019, the outbreak of the 2019 novel coronavirus disease (COVID-19) infection has become a major epidemic threat in China. As of Feb 11, 2020, the cumulative number of confirmed cases in mainland China has reached 38 800, with 4740 (12·2%) cured cases and 1113 (2·9%) deaths; additionally, there have been 16 067 suspected cases so far.1 All 31 provinces in mainland China have now adopted the first-level response to major public health emergencies. The National Health Commission of China has published a series of guidelines on the prevention, diagnosis, and treatment of COVID-19 pneumonia, based on growing evidence of the pathogens responsible for COVID-19 infection, as well as the epidemiological characteristics, clinical features, and the most effective treatments.2, 3, 4 The central government and some provincial governments have provided food and medical supplies and dispatched expert groups and medical teams to manage and control the outbreak response in the hardest-hit areas (Wuhan and neighbouring cities in Hubei province).
    135浏览量
    原文链接